Apex Biotechnology Corp (1733) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.003x

Based on the latest financial reports, Apex Biotechnology Corp (1733) has a cash flow conversion efficiency ratio of 0.003x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (NT$5.19 Million ≈ $163.42K USD) by net assets (NT$1.81 Billion ≈ $57.17 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Apex Biotechnology Corp market capitalisation for the company's overall valuation and market capitalisation.

Apex Biotechnology Corp - Cash Flow Conversion Efficiency Trend (2002–2024)

This chart illustrates how Apex Biotechnology Corp's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Apex Biotechnology Corp Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Apex Biotechnology Corp ranked by their cash flow conversion efficiency. Explore 1733 cash flow quality index to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
Graha Andrasentra Propertindo Tbk PT JK:JGLE	0.004x
Investcorp India Acquisition Corp. Class A ordinary share NASDAQ:IVCA	-0.004x
China Container Terminal Corp TW:2613	0.063x
Arihant Capital Markets Limited NSE:ARIHANTCAP	-0.250x
Economic Investment Trust Ltd TO:EVT	0.095x
Zuari Agro Chemicals Limited NSE:ZUARI	0.202x
Axis Corporation TWO:6292	0.190x
Wrap Technologies Inc NASDAQ:WRAP	-0.182x

Annual Cash Flow Conversion Efficiency for Apex Biotechnology Corp (2002–2024)

The table below shows the annual cash flow conversion efficiency of Apex Biotechnology Corp from 2002 to 2024. View Apex Biotechnology Corp stock quote for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	NT$1.82 Billion ≈ $57.47 Million	NT$328.67 Million ≈ $10.35 Million	0.180x	+40.52%
2023-12-31	NT$1.80 Billion ≈ $56.61 Million	NT$230.39 Million ≈ $7.26 Million	0.128x	+775.71%
2022-12-31	NT$1.82 Billion ≈ $57.27 Million	NT$26.62 Million ≈ $838.55K	0.015x	-85.73%
2021-12-31	NT$1.75 Billion ≈ $55.25 Million	NT$179.87 Million ≈ $5.67 Million	0.103x	-39.83%
2020-12-31	NT$1.65 Billion ≈ $51.86 Million	NT$280.60 Million ≈ $8.84 Million	0.170x	-38.20%
2019-12-31	NT$1.68 Billion ≈ $52.83 Million	NT$462.52 Million ≈ $14.57 Million	0.276x	+571.12%
2018-12-31	NT$1.64 Billion ≈ $51.79 Million	NT$67.57 Million ≈ $2.13 Million	0.041x	-3.39%
2017-12-31	NT$1.66 Billion ≈ $52.45 Million	NT$70.83 Million ≈ $2.23 Million	0.043x	-75.27%
2016-12-31	NT$1.73 Billion ≈ $54.58 Million	NT$298.06 Million ≈ $9.39 Million	0.172x	-29.67%
2015-12-31	NT$1.93 Billion ≈ $60.80 Million	NT$472.15 Million ≈ $14.88 Million	0.245x	+70.64%
2014-12-31	NT$1.87 Billion ≈ $58.80 Million	NT$267.60 Million ≈ $8.43 Million	0.143x	-43.20%
2013-12-31	NT$1.92 Billion ≈ $60.51 Million	NT$484.77 Million ≈ $15.27 Million	0.252x	-0.31%
2012-12-31	NT$2.01 Billion ≈ $63.41 Million	NT$509.67 Million ≈ $16.06 Million	0.253x	+62.08%
2011-12-31	NT$1.75 Billion ≈ $55.14 Million	NT$273.45 Million ≈ $8.62 Million	0.156x	-45.31%
2010-12-31	NT$1.63 Billion ≈ $51.35 Million	NT$465.59 Million ≈ $14.67 Million	0.286x	+7.41%
2009-12-31	NT$1.47 Billion ≈ $46.35 Million	NT$391.29 Million ≈ $12.33 Million	0.266x	+12.09%
2008-12-31	NT$1.26 Billion ≈ $39.83 Million	NT$299.96 Million ≈ $9.45 Million	0.237x	-12.21%
2007-12-31	NT$1.35 Billion ≈ $42.50 Million	NT$364.62 Million ≈ $11.49 Million	0.270x	-18.07%
2006-12-31	NT$1.10 Billion ≈ $34.74 Million	NT$363.71 Million ≈ $11.46 Million	0.330x	+39.47%
2005-12-31	NT$896.93 Million ≈ $28.26 Million	NT$212.14 Million ≈ $6.68 Million	0.237x	-6.29%
2004-12-31	NT$865.91 Million ≈ $27.28 Million	NT$218.54 Million ≈ $6.89 Million	0.252x	-29.66%
2003-12-31	NT$842.42 Million ≈ $26.54 Million	NT$302.25 Million ≈ $9.52 Million	0.359x	+221.73%
2002-12-31	NT$712.76 Million ≈ $22.46 Million	NT$79.49 Million ≈ $2.50 Million	0.112x	--

About Apex Biotechnology Corp

TW:1733 Taiwan Biotechnology

Market Cap

$95.26 Million

NT$3.02 Billion TWD

Market Cap Rank

#19446 Global

#1099 in Taiwan

Share Price

NT$30.25

Change (1 day)

+1.17%

52-Week Range

NT$28.20 - NT$37.50

All Time High

NT$42.96